Business · 19/10/2022Updated: 10/17/2026 · 1 min read
FDA Amends Pulmonary-Allergy Drugs Advisory Committee Meeting Notice
The FDA is updating the meeting details of the Pulmonary-Allergy Drugs Advisory Committee, originally announced on September 8, 2022, to reflect changes in the meeting schedule and supplementary information, following the submission of new information for review.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →